Abbott Plans to Spin Off Global Nutrition Business by End of 2027

The two-year runway to completion, paired with an explicit carve-out that leaves 2026 guidance untouched, suggests Abbott is framing this as a structural simplification rather than a response to near-term pressure — a distinction that matters for how the remaining business will be valued once nutrition is removed from the earnings base. The disclosure is thin on terms, so the segment's standalone scale, capital structure and management remain unknown, and those details will determine whether the spun-off entity reads as a focused consumer franchise or a slower-growth cast-off. Whether Abbott provides interim financial detail on the nutrition unit before the separation is the open question worth watching.